Bruce D. Jackson
Stock Analyst at Benchmark
(1.10)
# 3,773
Out of 4,996 analysts
4
Total ratings
50%
Success rate
-9.01%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Bruce D. Jackson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RVPH Reviva Pharmaceuticals Holdings | Maintains: Speculative Buy | $14 → $7 | $0.30 | +2,272.88% | 1 | Sep 15, 2025 | |
| UNCY Unicycive Therapeutics | Maintains: Speculative Buy | $3 → $21 | $4.02 | +422.39% | 1 | Sep 15, 2025 | |
| HBIO Harvard Bioscience | Maintains: Speculative Buy | $3 → $2 | $0.44 | +350.55% | 1 | Sep 10, 2025 | |
| CLNN Clene | Maintains: Buy | $33 → $31 | $5.81 | +433.56% | 1 | Sep 10, 2025 |
Reviva Pharmaceuticals Holdings
Sep 15, 2025
Maintains: Speculative Buy
Price Target: $14 → $7
Current: $0.30
Upside: +2,272.88%
Unicycive Therapeutics
Sep 15, 2025
Maintains: Speculative Buy
Price Target: $3 → $21
Current: $4.02
Upside: +422.39%
Harvard Bioscience
Sep 10, 2025
Maintains: Speculative Buy
Price Target: $3 → $2
Current: $0.44
Upside: +350.55%
Clene
Sep 10, 2025
Maintains: Buy
Price Target: $33 → $31
Current: $5.81
Upside: +433.56%